Winters B - Search Results

1

Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype.

Altmann A, Sing T, Vermeiren H, Winters B, Van Craenenbroeck E, Van der Borght K, Rhee SY, Shafer RW, Schülter E, Kaiser R, Peres Y, Sönnerborg A, Fessel WJ, Incardona F, Zazzi M, Bacheler L, Van Vlijmen H, Lengauer T. Altmann A, et al. Among authors: winters b. Antivir Ther. 2009;14(2):273-83. Antivir Ther. 2009. PMID: 19430102

2

Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixtures.

Winters B, Van Craenenbroeck E, Van der Borght K, Lecocq P, Villacian J, Bacheler L. Winters B, et al. J Virol Methods. 2009 Dec;162(1-2):101-8. doi: 10.1016/j.jviromet.2009.07.023. Epub 2009 Aug 3. J Virol Methods. 2009. PMID: 19654022

3

A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences.

Steegen K, Bronze M, Van Craenenbroeck E, Winters B, Van der Borght K, Wallis CL, Stevens W, Rinke de Wit TF, Stuyver LJ; ART-A consortium. Steegen K, et al. Among authors: winters b. AIDS Res Ther. 2010 Oct 15;7:38. doi: 10.1186/1742-6405-7-38. AIDS Res Ther. 2010. PMID: 20950432 Free PMC article.

4

Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data.

Winters B, Montaner J, Harrigan PR, Gazzard B, Pozniak A, Miller MD, Emery S, van Leth F, Robinson P, Baxter JD, Perez-Elias M, Castor D, Hammer S, Rinehart A, Vermeiren H, Van Craenenbroeck E, Bacheler L. Winters B, et al. J Acquir Immune Defic Syndr. 2008 May 1;48(1):26-34. doi: 10.1097/QAI.0b013e31816d9bf4. J Acquir Immune Defic Syndr. 2008. PMID: 18360290

5

The influence of the M184V mutation in HIV-1 reverse transcriptase on the virological outcome of highly active antiretroviral therapy regimens with or without didanosine.

Sproat M, Pozniak AL, Peeters M, Winters B, Hoetelmans R, Graham NM, Gazzard BG. Sproat M, et al. Among authors: winters b. Antivir Ther. 2005;10(2):357-61. Antivir Ther. 2005. PMID: 15865231

6

Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study).

Pellegrin I, Wittkop L, Joubert LM, Neau D, Bollens D, Bonarek M, Girard PM, Fleury H, Winters B, Saux MC, Pellegrin JL, Thiébaut R, Breilh D; ANRS Co3 Aquitaine Cohort. Pellegrin I, et al. Among authors: winters b. Antivir Ther. 2008;13(2):271-9. Antivir Ther. 2008. PMID: 18505178

7

Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals.

Sista P, Rinehart A, Wasikowski B, Winters B, Pattery T, Bacheler L. Sista P, et al. Among authors: winters b. J Clin Virol. 2009 Mar;44(3):190-4. doi: 10.1016/j.jcv.2008.12.005. Epub 2009 Jan 24. J Clin Virol. 2009. PMID: 19168389

8

A combined genotypic and phenotypic human immunodeficiency virus type 1 recombinant virus assay for the reverse transcriptase and integrase genes.

Van Baelen K, Rondelez E, Van Eygen V, Ariën K, Clynhens M, Van den Zegel P, Winters B, Stuyver LJ. Van Baelen K, et al. Among authors: winters b. J Virol Methods. 2009 Nov;161(2):231-9. doi: 10.1016/j.jviromet.2009.06.015. Epub 2009 Jun 25. J Virol Methods. 2009. PMID: 19559730

9

A synthetic HIV-1 subtype C backbone generates comparable PR and RT resistance profiles to a subtype B backbone in a recombinant virus assay.

Nauwelaers D, Van Houtte M, Winters B, Steegen K, Van Baelen K, Chi E, Zhou M, Steiner D, Bonesteel R, Aston C, Stuyver LJ. Nauwelaers D, et al. Among authors: winters b. PLoS One. 2011;6(5):e19643. doi: 10.1371/journal.pone.0019643. Epub 2011 May 24. PLoS One. 2011. PMID: 21629677 Free PMC article.

10

CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA.

Verhofstede C, Vandekerckhove L, Eygen VV, Demecheleer E, Vandenbroucke I, Winters B, Plum J, Vogelaers D, Stuyver L. Verhofstede C, et al. Among authors: winters b. J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):126-36. doi: 10.1097/QAI.0b013e31819118fa. J Acquir Immune Defic Syndr. 2009. PMID: 19131897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page